Search results for "mRNA manufacturing"

Article Can Vaccine Development Be Safely Accelerated?
Can Vaccine Development Be Safely Accelerated? Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe. By Cynthia A. Ch…

Article Top Process Development Trends for 2021 and a Look into 2022
This infographic takes you through, step by step, the mRNA manufacturing workflow process—from plasmid linearization and buffer exchange to polishing and drug product. Because of its manufacturing per…

Article mRNA: The Messenger - mRNA Product Purification
Explore the mRNA universe with Cytiva. Join us for part 4 of mRNA : the messenger, where we discuss key considerations for the purification of the mRNA product, including the various m…

Article Platform Technologies Improve Protein Expression
Platform technologies facilitate development and accelerate commercialization of protein therapeutics. By Cynthia A. Challener    Speed to market is essential in the biopharmaceutica…

Article A Closer Look at Affinity Ligands
Affinity ligands play an exciting role in the ever-growing sphere of downstream processing. In speaking with BioPharm International®, Phillip Elliott, PhD, associate director of Process Development,…

Article mRNA: The Messenger - mRNA Synthesis
Explore the mRNA universe with Cytiva. Join us for part 3 of mRNA: the messenger, where we discuss key considerations for the synthesis of RNA molecules, including optimizing the…

Article mRNA: the messenger
Exploring the mRNA manufacturing universe? Proceed with confidence with some top tips from our scientists on mRNA synthesis and production.  Watch the video to learn more about how early d…

Article Enhancing Resins Addresses Purification Concerns
Christoph Burgstedt/Stock.Adobe.com Enhancement of resin technology can improve the ability of chromatography to purify the growing landscape of increasingly complex biomolecu…

Article mRNA Therapeutics and Vaccines – Key Process Considerations
Click here >> Learn more on key considerations and strategies for process development and scaling up in our new web hub for mRNA therapeutics and vaccines.

Article mRNA: The messenger - LNP formulation
Explore the mRNA universe with Cytiva. Join us for part 5 of mRNA: the messenger, where we discuss key considerations for the formulation of lipid nanoparticles (LNPs) for mRNA drug d…

Previous PageNext Page